Data quality and patient characteristics in European ANCA-associated vasculitis registries: data retrieval by federated querying

Author:

Gisslander KarlORCID,Rutherford MatthewORCID,Aslett LouisORCID,Basu NeilORCID,Dradin FrançoisORCID,Hederman LucyORCID,Hruskova ZdenkaORCID,Kardaoui HichamORCID,Lamprecht PeterORCID,Lichołai SabinaORCID,Musial JacekORCID,O’Sullivan DeclanORCID,Puechal XavierORCID,Scott JenniferORCID,Segelmark MårtenORCID,Straka RichardORCID,Terrier BenjaminORCID,Tesar VladimirORCID,Tesi MichelangeloORCID,Vaglio AugustoORCID,Wandrei DagmarORCID,White ArthurORCID,Wójcik KrzysztofORCID,Yaman BeyzaORCID,Little Mark AORCID,Mohammad Aladdin JORCID

Abstract

ObjectivesThis study aims to describe the data structure and harmonisation process, explore data quality and define characteristics, treatment, and outcomes of patients across six federated antineutrophil cytoplasmic antibody-associated vasculitis (AAV) registries.MethodsThrough creation of the vasculitis-specific Findable, Accessible, Interoperable, Reusable, VASCulitis ontology, we harmonised the registries and enabled semantic interoperability. We assessed data quality across the domains of uniqueness, consistency, completeness and correctness. Aggregated data were retrieved using the semantic query language SPARQL Protocol and Resource Description Framework Query Language (SPARQL) and outcome rates were assessed through random effects meta-analysis.ResultsA total of 5282 cases of AAV were identified. Uniqueness and data-type consistency were 100% across all assessed variables. Completeness and correctness varied from 49%–100% to 60%–100%, respectively. There were 2754 (52.1%) cases classified as granulomatosis with polyangiitis (GPA), 1580 (29.9%) as microscopic polyangiitis and 937 (17.7%) as eosinophilic GPA. The pattern of organ involvement included: lung in 3281 (65.1%), ear-nose-throat in 2860 (56.7%) and kidney in 2534 (50.2%). Intravenous cyclophosphamide was used as remission induction therapy in 982 (50.7%), rituximab in 505 (17.7%) and pulsed intravenous glucocorticoid use was highly variable (11%–91%). Overall mortality and incidence rates of end-stage kidney disease were 28.8 (95% CI 19.7 to 42.2) and 24.8 (95% CI 19.7 to 31.1) per 1000 patient-years, respectively.ConclusionsIn the largest reported AAV cohort-study, we federated patient registries using semantic web technologies and highlighted concerns about data quality. The comparison of patient characteristics, treatment and outcomes was hampered by heterogeneous recruitment settings.

Funder

DFG project

European Regional Development Fund

Science Foundation Ireland

French Vasculitis Study Group

Horizon 2020 Framework Programme

Crafoordska Stiftelsen

Health Research Board

German Research Foundation / Deutsche Forschungsgemeinschaft

CSL Vifor

Wellcome Trust

Vetenskapsrådet

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference44 articles.

1. Rathmann J , Segelmark M , Englund M , et al . Stable incidence but increase in prevalence of ANCA-associated vasculitis in southern Sweden: a 23-year study. RMD Open 2023;9:e002949. doi:10.1136/rmdopen-2022-002949

2. Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis;Sánchez Álamo;Nephrol Dial Transplant,2023

3. The sound of interconnectivity; the European vasculitis society 2022 report;Egan;Kidney Int Rep,2022

4. FAIRVASC: building registry interoperability to inform clinical care. 2023. Available: https://fairvasc.eu/ [Accessed 7 Jun 2023].

5. European joint programme for rare diseases. 2023. Available: https://www.ejprarediseases.org/ [Accessed 7 Jun 2023].

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3